Fusobacterium Nucleatum in Colorectal Cancer: Relationship Among Immune Modulation, Potential Biomarkers and Therapeutic Implications
Dalila Incognito(University of Messina), Massimiliano Berretta(University of Messina), Salvatore Berretta, Pierluigi Consolo, Giuliana Ciappina(University of Ferrara), Alessandro Ottaiano(Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"), Nicola Maurea(Cancer Institute (WIA)), Tindara Franchina(University of Messina), Alessandra Scano, Claudia Gelsomino(University of Messina), Vincenzo Quagliariello(Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale")
Cited by 18
Related Papers
The SGLT-2 inhibitor empagliflozin improves myocardial strain, reduces cardiac fibrosis and pro-inflammatory cytokines in non-diabetic mice treated with doxorubicin
|Cardiovascular Diabetology|2021|368
FGFR a promising druggable target in cancer: Molecular biology and new drugs
|Critical Reviews in Oncology/Hematology|2017|203
Trastuzumab Adjuvant Chemotherapy and Cardiotoxicity in Real-World Women With Breast Cancer
|Journal of Cardiac Failure|2011|116
Metabolic syndrome affects breast cancer risk in postmenopausal women: National Cancer Institute of Naples experience
|Cancer Biology & Therapy|2010|108
Resveratrol in Cancer Patients: From Bench to Bedside
|International Journal of Molecular Sciences|2020|105